<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Cerebral preconditioning provides insights into endogenous mechanisms that protect the brain from ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp> and the <z:chebi fb="164" ids="38867">anesthetic</z:chebi> <z:chebi fb="0" ids="6015">isoflurane</z:chebi> are powerful preconditioning agents </plain></SENT>
<SENT sid="2" pm="."><plain>Recent data show that <z:chebi fb="0" ids="37550">sphingosine 1-phosphate</z:chebi> receptor stimulation improves outcome in <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Endogenous <z:chebi fb="0" ids="37550">sphingosine 1-phosphate</z:chebi> levels are controlled by the expression and activity of <z:chebi fb="0" ids="16393">sphingosine</z:chebi> kinases (SPK) </plain></SENT>
<SENT sid="4" pm="."><plain>We hypothesize that SPK upregulation mediates preconditioning induced by <z:chebi fb="0" ids="6015">isoflurane</z:chebi> and <z:mp ids='MP_0005039'>hypoxia</z:mp> and reduces ischemic injury </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Male <z:mp ids='MP_0002169'>wild-type</z:mp> C57BL/J, SPK1(-/-) and SPK2(-/-) mice were exposed to <z:chebi fb="0" ids="6015">isoflurane</z:chebi> or <z:mp ids='MP_0005039'>hypoxia</z:mp> preconditioning before transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume and neurological outcome were measured 24 hours later </plain></SENT>
<SENT sid="7" pm="."><plain>SPK inhibitors (SKI-II and ABC294640) were used to test the involvement of SPK2 </plain></SENT>
<SENT sid="8" pm="."><plain>Expressions of SPK1, SPK2, and <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor 1α were determined </plain></SENT>
<SENT sid="9" pm="."><plain>Primary cultures of mouse cortical neurons were exposed to <z:chebi fb="0" ids="6015">isoflurane</z:chebi> before <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>- or <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: <z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning and <z:mp ids='MP_0005039'>hypoxia</z:mp> preconditioning significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and improved neurological outcome in <z:mp ids='MP_0002169'>wild-type</z:mp> and SPK1(-/-) mice but not in SPK2(-/-) mice </plain></SENT>
<SENT sid="11" pm="."><plain>Pretreatment with SKI-II or ABC294640 abolished the <z:chebi fb="0" ids="6015">isoflurane</z:chebi> preconditioning-induced tolerance </plain></SENT>
<SENT sid="12" pm="."><plain>Western blot showed a rapid and sustained increase in SPK2 level, whereas SPK1 level was similar between preconditioned mice and controls </plain></SENT>
<SENT sid="13" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-inducible factor 1α was upregulated in <z:mp ids='MP_0002169'>wild-type</z:mp> <z:chebi fb="0" ids="6015">isoflurane</z:chebi>-preconditioned mice but not in SPK2(-/-) </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="0" ids="6015">Isoflurane</z:chebi> preconditioning protected primary neurons against cell <z:hpo ids='HP_0011420'>death</z:hpo>, which was abolished in ABC294640-treated cells </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: Applying genetic and pharmacological approaches, we demonstrate that neuronal SPK2 isoform plays an important role in cerebral preconditioning </plain></SENT>
</text></document>